We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Life Science Reit Plc | LSE:LABS | London | Ordinary Share | GB00BP5X4Q29 | ORD GBP0.01 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.40 | 1.02% | 39.80 | 39.80 | 40.20 | 40.10 | 39.50 | 39.90 | 933,022 | 15:27:49 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Real Estate Investment Trust | 15.71M | -27.61M | -0.0789 | -5.04 | 139.3M |
Date | Subject | Author | Discuss |
---|---|---|---|
27/2/2023 12:39 | Needs to go to Specsavers🤔 | jonwig | |
27/2/2023 10:53 | >> Jon £150k per year | toffeeman | |
27/2/2023 07:26 | New 10yr lease signed at OTP: No money details given, unfortunately. Also FY results 27 March, with live audio provided of presentation: | jonwig | |
13/2/2023 17:00 | I suspect that we will have to wait until end of March, when we get the results, before we see any significant upwards movement in share price At that point I am confident that NAV will be shown to be around the last published 102p (maybe higher with demand exceeding supply in the sector). I had a little nibble again today and may well add a few more before March. | gbcol | |
13/2/2023 11:20 | cheis - I don't think debt is a problem. LTV wass 9.5% at 30/06 last. Interest rate is capped, I think. Like Col said, It's a head scratcher! | jonwig | |
13/2/2023 10:51 | I assume there were some debt structure concerns with exposure to rising rates...... | chrisdgb | |
13/2/2023 10:32 | My instincts tell me I should be getting more of these but I already have a substantial holding (at a substantial loss) and that drop from over 90p to 70p was brutal and rather than recover like many others did, share price has continued to fall and I really don’t understand why. | gbcol | |
13/2/2023 10:22 | Jefferies pushing the stock this morning, highlight the lag compared to peer group and 35% discount to nav, also the robust letting at Rolling Stock yard......... | chrisdgb | |
13/2/2023 07:21 | Looks like my #76 was only half the story: A lack of laboratory space in Oxford and Cambridge threatens to thwart Rishi Sunak’s dream of making Britain a “science superpower”. In both cities, there are almost no labs left for growing life sciences businesses to move into. Bidwells, the commercial property agent, estimates that there is 10,000 sq ft of space available in Cambridge, compared with two million sq ft of demand. There is a similar picture in Oxford, where there is about 25,000 sq ft available compared with requirements from businesses of 845,000 sq ft. Developers are rushing through new projects to try to catch up with demand. More - | jonwig | |
10/2/2023 15:03 | Divi should be half yearly, so next one will presumably be paid end April. | gbcol | |
10/2/2023 12:55 | gbcol you are dead right about the lack of information. I don't even know if this pays a quarterly dividend or half yearly. Does anyone know? | orinocor | |
10/2/2023 09:29 | Yes this was originally trading on AIM see RNS back in November re move to main market. | gbcol | |
10/2/2023 08:42 | Are you saying this was trading on AIM at the beginning? Quite unusual for a REIT | aamhager | |
10/2/2023 08:24 | The fall-out from Astra-Zeneca's announcement this week might have some effect. Other life science firms are warning that the UK is in danger of losing its self-proclaimed advantages by high corporation taxes. LABS isn't a big enough player to be directly affected, I would think, but capital values might suffer and its NAV slip back. | jonwig | |
10/2/2023 08:12 | I’ve emailed the company as I think the lack of updates is rather poor - last published NAV is 8 months out of date for example. Also I can’t see a list of major shareholders on their website. I suspect we will have to wait until end of March when results are issued but I felt they needed a nudge. They may be content to sit back while the share price plummets but I’m not. | gbcol | |
10/2/2023 08:07 | Re stamp duty, this is a result of the movement from AIM to the main market. Previously on AIM there wasn’t SD charged (that’s when I did most of my purchases) but now it is. The move hasn’t provided us shareholders with any tangible benefits yet, that’s for sure. | gbcol | |
09/2/2023 16:59 | Does it show stamp duty when you try to get a quote? | aamhager | |
09/2/2023 16:54 | I’ve bought plenty of these with AJ Bell and never paid stamp duty. Really don’t understand why this is doing so badly in terms of discount to NAV although there is obviously a big seller out there (> 2 million sold today). Frustrating but I’m confident it will turn at some point as long as they keep up the divi. | gbcol | |
09/2/2023 15:01 | Not with IG. I bought 3000 at 65.3p. Cost for a trade is £3 The total cost was £1962. This is what IG have charged me, | orinocor | |
09/2/2023 14:41 | You might want to check the trade confirmation. Stamp duty is due on this one | aamhager | |
09/2/2023 14:31 | I tried with iweb and they are charging stamp duty as well. IG rules | orinocor | |
09/2/2023 14:29 | Not a spreadbet just a straight share trading account. 65.3p to buy now. | orinocor | |
09/2/2023 14:22 | Spread bet/ CFD?I tried through ajbell and they added a stamp duty to the quote as well | aamhager | |
09/2/2023 14:01 | sorry no it was IG | orinocor |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions